0 CHECKOUT
Global Self-monitoring Blood Glucose Devices Market 2015-2019 - Product Image

Global Self-monitoring Blood Glucose Devices Market 2015-2019

  • ID: 3386640
  • August 2015
  • Region: Global
  • 60 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen
  • Bioptik Technology
  • Grove Instruments
  • LifeScan
  • Medtronic
  • MORE

About self-monitoring blood glucose device

Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment.

The analysts forecast the global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019.

Covered in this report
The report includes the present scenario and the growth prospects of the global self-monitoring blood glucose devices market for the period 2015-2019. To calculate the market size, The authoruses revenue generated from the sales of self-monitoring blood glucose devices.

The report, Global Self-monitoring Blood Glucose Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen
  • Bioptik Technology
  • Grove Instruments
  • LifeScan
  • Medtronic
  • MORE

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: SMBG: An overview
Background
Definition
Complications of diabetes
PART 06: Incidence and prevalence
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by type of SMBG components
Global blood glucose test strips market
Global lancets market
Global blood glucose meters market
PART 09: Geographical segmentation
SMBG devices market in Americas
SMBG devices market in EMEA
SMBG devices market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key Vendor Analysis
Abbott Diagnostics
Bayer Healthcare
LifeScan
Roche Diagnostics
PART 17: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Categorization of SMBG devices by generation
Exhibit 03: Distribution channel overview of SMBG devices
Exhibit 04: Prevalence of diabetes 2013
Exhibit 05: Prevalence of diabetes 2013
Exhibit 06: Various treatment methods for diabetes management (%)
Exhibit 07: Global SMBG devices market 2014-2019 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Global SMBG devices market segmentation by components
Exhibit 10: SMBG meters segmentation 2014
Exhibit 11: Global SMBG devices market segmentation by components 2014
Exhibit 12: Global blood glucose test strips market 2014-2019 ($ billions)
Exhibit 13: Global lancets market 2014-2019 ($ billions)
Exhibit 14: Global blood glucose meters market 2014-2019 ($ billions)
Exhibit 15: Global SMBG devices market segmentation by components 2014-2019 ($ billions)
Exhibit 16: Global SMBG devices market segmentation by components 2014-2019
Exhibit 17: Global SMBG devices market segmentation by geography 2014-2019
Exhibit 18: SMBG devices market in Americas 2014-2019 ($ billions)
Exhibit 19: SMBG devices market in EMEA 2014-2019 ($ billions)
Exhibit 20: SMBG devices market in APAC 2014-2019 ($ billions)
Exhibit 21: SMBG devices market segmentation by geography 2014-2019 ($ billions)
Exhibit 22: Global SMBG devices market segmentation by geography 2014-2019
Exhibit 23: Impact of drivers
Exhibit 24: Impact of drivers and challenges
Exhibit 25: Market share analysis of top vendors 2014
Exhibit 26: Abbott Diagnostics: Key takeaways
Exhibit 27: Bayer Healthcare: Key takeaways
Exhibit 28: LifeScan: Key takeaways
Exhibit 29: Roche: Key takeaways
Exhibit 30: Abbott Diagnostics: Key business offerings

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen
  • Bioptik Technology
  • Grove Instruments
  • LifeScan
  • Medtronic
  • MORE

New Report Released: – Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2015-2019

The author of the report recognizes the following companies as the key players in the Global Automotive Clutch Market: Abbott Laboratories, Arkray, Bayer Healthcare, LifeScan and Roche Diagnostics

Other Prominent Vendors in the market are: Animas, B. Braun Melsungen, Bionime, Bioptik Technology, Chongqing Haray International Business, Dexcom, Gluco-Ease, LabStyle Innovations, Integrity Applications, M Pharmaceutical, Medtronic, Medisana, Nipro Diagnostics, Nova Biomedical, OrSense, Sunrising Enterprise, Tekcapital, Grove Instruments and Wuhan HNC Technology

Commenting on the report, an analyst from the team said: “Though diabetes is a chronic metabolic condition, it can be controlled with proper medication, and dietary and lifestyle management. Most people prefer SMBG devices for convenient monitoring of blood glucose levels. Moreover, regular blood glucose testing is the cornerstone of effective diabetes management. Usage of blood glucose test strips and meters at home can help patients obtain an accurate blood glucose level reading within few seconds. This trend is anticipated to have a significant impact on the SMBG devices market.”

According to the report, according to WHO, the number of people aged 60 and above will increase tremendously by 2050. By 2030, more than 22% of the world's population will be over 65 years. Almost one-third of the elderly people over the age of 65 are affected by diabetes. The Americas is reported to have a high elderly population, which is estimated to grow at a minimal rate by 2050. Similarly, in Europe, the elderly population will increase by 2050 because of an increase in life expectancy and advances in the healthcare industry. The percentage of the elderly population in APAC is low, including China and India. However, the region will have the largest aging population by 2050.

Further, the report states that the presence of alternative methods of glucose monitoring could hinder the growth of the SMBG devices market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown
4 of 5

- Abbott Laboratories
- Arkray
- Bayer Healthcare
- LifeScan
- Roche Diagnostics
- Animas
- B. Braun Melsungen
- Bionime
- Bioptik Technology
- Chongqing Haray International Business
- Dexcom
- Gluco-Ease
- LabStyle Innovations
- Integrity Applications
- M Pharmaceutical
- Medtronic
- Medisana
- Nipro Diagnostics
- Nova Biomedical
- OrSense
- Sunrising Enterprise
- Tekcapital
- Grove Instruments
- Wuhan HNC Technology

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fisher & Paykel Healthcare Limited
  • Philips N.V.
  • Raumedic AG
  • Walgreen's Company
  • Invacare Corporation
  • Johnson & Johnson Services, Inc.